Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
Ginguay A, Kramkimel N, Lecolant S, Goldwasser F, Battistella M, Arrondeau J. Ginguay A, et al. Among authors: battistella m. Case Rep Oncol. 2022 Dec 21;15(3):1114-1119. doi: 10.1159/000525524. eCollection 2022 Sep-Dec. Case Rep Oncol. 2022. PMID: 36655184 Free PMC article.
[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part].
Seris A, Battistella M, Beylot-Barry M, Dalle S, Mortier L, Lebbé C, Blom A, Neidhart-Berard EM, Kramkimel N, Dupuy A, Zehou O, Dalac S, Jullie ML, Cribier B, Jouary T; Pour CARADERM, réseau de cancers rares dermatologiques (www.caraderm.org); le Groupe de cancérologie cutanée de la Société française de dermatologie. Seris A, et al. Among authors: battistella m. Ann Dermatol Venereol. 2019 Nov;146(11):704-710. doi: 10.1016/j.annder.2019.07.006. Epub 2019 Sep 30. Ann Dermatol Venereol. 2019. PMID: 31582261 French.
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.
Zagala R, Dalle S, Beylot-Barry M, Meyer N, Saiag P, Kramkimel N, Lebbe C, Zehou O, Amini-Adle M, Grob JJ, Arnault JP, Maubec E, Granel-Brocard F, Cribier B, Quereux G, Brunet-Possenti F, Dalac S, Dereure O, Drumez E, Mortier L, Battistella M, Jouary T. Zagala R, et al. Among authors: battistella m. J Eur Acad Dermatol Venereol. 2024 Jun 12. doi: 10.1111/jdv.20155. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38864258
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study.
Delyon J, Biard L, Renaud M, Resche-Rigon M, Le Goff J, Dalle S, Heidelberger V, Da Meda L, Toullec L, Carcelain G, Mourah S, Caillat-Zucman S, Allain V, Battistella M, Lebbe C. Delyon J, et al. Among authors: battistella m. Lancet Oncol. 2022 Apr;23(4):491-500. doi: 10.1016/S1470-2045(22)00097-3. Epub 2022 Mar 10. Lancet Oncol. 2022. PMID: 35279271 Clinical Trial.
473 results